161 related articles for article (PubMed ID: 14575839)
1. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro.
Pauwels B; Korst AE; Pattyn GG; Lambrechts HA; Van Bockstaele DR; Vermeulen K; Lenjou M; de Pooter CM; Vermorken JB; Lardon F
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1075-83. PubMed ID: 14575839
[TBL] [Abstract][Full Text] [Related]
2. Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells.
Wouters A; Pauwels B; Lambrechts HA; Pattyn GG; Ides J; Baay M; Meijnders P; Peeters M; Vermorken JB; Lardon F
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):558-66. PubMed ID: 21377279
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53.
Pauwels B; Korst AE; Andriessen V; Baay MF; Pattyn GG; Lambrechts HA; Pooter CM; Lardon F; Vermorken JB
Radiat Res; 2005 Nov; 164(5):642-50. PubMed ID: 16238441
[TBL] [Abstract][Full Text] [Related]
4. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
Latz D; Fleckenstein K; Eble M; Blatter J; Wannenmacher M; Weber KJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):875-82. PubMed ID: 9652852
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation.
Supiot S; Thillays F; Rio E; Gouard S; Morgenstern A; Bruchertseifer F; Mahé MA; Chatal JF; Davodeau F; Chérel M
Radiother Oncol; 2007 Apr; 83(1):97-101. PubMed ID: 17383762
[TBL] [Abstract][Full Text] [Related]
7. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
[TBL] [Abstract][Full Text] [Related]
8. Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation.
Castro Kreder N; Van Bree C; Franken NA; Haveman J
J Radiat Res; 2004 Mar; 45(1):111-8. PubMed ID: 15133298
[TBL] [Abstract][Full Text] [Related]
9. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
Pauwels B; Korst AE; Lambrechts HA; Pattyn GG; de Pooter CM; Lardon F; Vermorken JB
Cancer Chemother Pharmacol; 2006 Aug; 58(2):219-28. PubMed ID: 16331496
[TBL] [Abstract][Full Text] [Related]
10. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
11. [Effect of gemcitabine in enhancing the radiosensitivity of HepG2 hepatoma cells and the possible mechanism].
Ling ZH; Sun QQ; Zhang YW; Guan J; Ding Y; Chen LH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1993-6. PubMed ID: 22200698
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
[TBL] [Abstract][Full Text] [Related]
13. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
[TBL] [Abstract][Full Text] [Related]
14. Unusual radiation response of gemcitabine-treated HeLa cells: reduced and enhanced survival.
Yang SJ; Zhang X; Jiang M; Ashamalla H; Rafla S
Cancer Lett; 2002 Dec; 187(1-2):179-83. PubMed ID: 12359366
[TBL] [Abstract][Full Text] [Related]
15. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
[TBL] [Abstract][Full Text] [Related]
16. Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line.
Castro Kreder N; Van Bree C; Franken NA; Haveman J
J Cancer Res Clin Oncol; 2003 Oct; 129(10):597-603. PubMed ID: 14513371
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines.
Robinson BW; Shewach DS
Clin Cancer Res; 2001 Aug; 7(8):2581-9. PubMed ID: 11489842
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.
Fechner G; Perabo FG; Schmidt DH; Haase L; Ludwig E; Schueller H; Blatter J; Mller SC; Albers P
Urology; 2003 Feb; 61(2):468-73. PubMed ID: 12597983
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.
Salem SD; Abou-Tarboush FM; Saeed NM; Al-Qadasi WD; Farah MA; Al-Buhairi M; Al-Harbi N; Alhazza I; Alsbeih G
Gene; 2012 May; 498(2):300-7. PubMed ID: 22353361
[TBL] [Abstract][Full Text] [Related]
20. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
